FDA Adverse Event Malfunction Summary report: N

VIDAS® TROPONIN I ULTRA

MDR report key: 5477511 · Received March 3, 2016

Report

Report Number
3002769706-2016-00042
Event Type
Malfunction
Date Received
March 3, 2016
Report Date
February 26, 2016
Manufacturer
BIOMERIEUX SA
Product Code
MMI
PMA / PMN Number
K063243
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX OF A FALSE POSITIVE RESULT INVOLVING VIDAS® TROPONIN I ULTRA LOT 1004203640/ 160724-0. AN INTERNAL BIOMÉRIEUX INVESTIGATION WAS PERFORMED WITH RESULTS AS FOLLOWS: NO OTHER COMPLAINTS FOR VIDAS® TROPONIN I ULTRA LOT 1004203640/ 160724-0. NO CAPA OR NONCONFORMITY LINKED WITH VIDAS® TROPONIN I ULTRA LOT 1004203640/ 160724-0. TESTS PERFORMED ON FOUR (4) INTERNAL SAMPLES FROM QUALITY CONTROL LABORATORY AND ONE EFS SAMPLE WITH VIDAS TROPONIN I ULTRA LOT 1004203640/ 160724-0 ON VIDAS® PC . RESULTS- THE FOUR (4) INTERNAL SAMPLES HAD RESULTS THAT WERE FOUND IN THEIR EXPECTED RANGES AND ONE (1) EFS SAMPLE WAS TESTED 8 TIMES, THE RESULTS WERE < 0.01 MICRO G / L EACH TIME. CONCLUSION- ABSENCE OF ANOMALY WITH VIDAS® TROPONIN I ULTRA LOT 1004203640/ 167024-0 CONFIRMED. PRODUCT PERFORMING WITHIN SPECIFICATIONS.

Description of Event or Problem · 1

A CUSTOMER IN THE UNITED STATES REPORTED NON REPETITIVE RESULTS WHILE USING THE; VIDAS TROPONIN I ULTRA REF (B)(4) LOT 1004203640. A RESULT OF 0.5UG/L WAS INITIALLY RECEIVED. THE DOCTOR REPEATED A SECOND TEST ON THE PATIENT IN THE EMERGENCY ROOM WITH A RESULT OF <0.01 UG/L. THE PATIENT WAS TESTED A THIRD TIME WITH A HEPARIN TUBE AND A SST TUBE WHICH RETURNED THE SAME RESULTS OF; <0.01 UG/L FOR EACH TUBE. A FINAL TEST WAS THEN RUN ON THE ORIGINAL TUBE TWICE WITH THE RETURN OF A FALSE RESULT OF; <0.01 UG/L.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
135002 VIDAS® TROPONIN I ULTRA VIDAS® TROPONIN I ULTRA MMI BIOMERIEUX SA 1004203640

Patients

Seq Age Sex Outcome Treatment
1